Skip to main content

Circulating intercellular adhesion molecule-1 (ICAM-1) in patients with hepatolithiasis

Abstract

We evaluated the role of circulating intercellular adhesion molecule-1 in the pathogenesis of hepatolithiasis. From December 1994 to May 1995, 40 patients with hepatolithiasis were included. All the patients met the following criteria: (1) presence of hepatolithiasis, (2) no obvious clinical evidence of an associated intrahepatic cholangiocarcinoma, (3) no clinical manifestation of cholangitis for at least 72 hr, (4) no immunomodulatory agents in the last three weeks, and (5) no blood transfusion in the last three weeks. Venous blood samples were collected both before surgery and at least three months after complete clearance of the stones, and the serum concentrations of circulating intercellular adhesion molecule-1 were measured with a sand-wich enzyme immunoassay method. Fifteen healthy subjects were used as a control group. Bile specimens routinely obtained during surgery were cultured for aerobes and anaerobes. The x-ray films of cholangiography were all reviewed in detail. The mean value (834±128 ng/ml) of circulating intercellular adhesion molecule-1 (ICAM-1) in the patient group before surgery was significantly higher than that (346±68 ng/ml) of the control group (P<0.01). The mean value (677±139 ng/ml) of circulating ICAM-1 in the patient group at least three months after complete clearance of the stones was significantly lower than that (834±128 ng/ml) of the patients before surgery (P<0.01), but this mean value (677±139 ng/ml) was still significantly higher than that (346±68 ng/ml) of the control group (P<0.01). Bacteria was present in the bile of all patients. The total number of bacterial species was 135, and there were an average of 3.4 bacterial species cultured per patient. Intrahepatic stricture was demonstrated in cholangiography in 33 patients (82.5%). In addition to the high incidence of intrahepatic bile duct strictures and bile infection, a significant elevation in circulating intercellular adhesion molecule-1 (sICAM-1) was shown in patients with hepatolithiasis. Our preliminary results seem to be promising and the real role of sICAM-1 deserves further investigation and elucidation.

This is a preview of subscription content, access via your institution.

References

  1. Springer TA: Adhesion receptors of the immune system. Nature 346:425–434, 1990

    PubMed  Google Scholar 

  2. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA: Primary structure of intercellular adhesion moledule 1(ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52:925–933, 1988

    PubMed  Google Scholar 

  3. Diamond MS, Staunton DE, DeFougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, et al: ICAM-1(CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111:3129–3139, 1990

    PubMed  Google Scholar 

  4. Makgoba MW, Sanders ME, Luce GEG, Gugel EA, Dustin ML, Springer TA, et al: Functional evidence that ICAM-1 is a ligand for LFA-1 in cytotoxic T cell recognition. Eur J Immunol 18:637–640, 1988

    PubMed  Google Scholar 

  5. Cosimi AB, Conti D, Delmonico FL, et al:In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 144:4604–4612, 1990

    PubMed  Google Scholar 

  6. Dougherty GJ, Murdoch S, Hogg N: The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 180:35–39, 1988

    Google Scholar 

  7. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neubergen JM: Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 2:1122–1124, 1989

    PubMed  Google Scholar 

  8. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM: Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 14:426–431, 1991

    PubMed  Google Scholar 

  9. Volpes R, Van den Oord JJ, Desmet VJ: Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 12:59–65, 1990

    PubMed  Google Scholar 

  10. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD: A form of circulating ICAM-1 in human serum. J Immunol 147:3788–3793, 1991

    PubMed  Google Scholar 

  11. Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E, et al: Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 16:810–814, 1992

    PubMed  Google Scholar 

  12. Zohren G, Armbrust T, Pirzer U, Bus Chenfelde K-H MZ, Ramadori G: Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: Relationship to disease activity and cirrhosis. Hepatology 18:798–802, 1993

    PubMed  Google Scholar 

  13. Sheen-Chen SM, Cheng YF, Chou FF, Lee TY: Ductal dilatation and stenting make routine hepatectomy unnecessary for left hepatolithiasis with intrahepatic biliary stricture. Surgery 117:32–36, 1995

    PubMed  Google Scholar 

  14. Sheen-Chen SM, Cheng YF, Chou FF, Lee TY: Postoperative T-tube cholangiography: is routine antibiotic prophylaxis necessary? A prospective controlled study. Arch Surg 130:20–23, 1995

    PubMed  Google Scholar 

  15. Lee WJ, Chang KJ, Lee CS, Chen KM: Surgery in cholangitis: Bacteriology and choice of antibiotic. Hepatogastroenterology 39:347–349, 1992

    PubMed  Google Scholar 

  16. Ker CG, Hwang CH, Chen JS, Lee KT, Sheen PC: Extracorporeal shockwave lithoripsy for treatment of intrahepatic stones:In vitro andin vivo studies. Hepatogastroenterology 40:159–162, 1993

    PubMed  Google Scholar 

  17. Lee KT, Sheen PC: Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct. J Surg Oncol 59:131–135, 1995

    PubMed  Google Scholar 

  18. Sheen-Chen SM, Chou FF, Eng HL: Intrahepatic cholangiocarcinoma in hepatolithiasis: A frequently overlooked disease. J Surg Oncol 47:131–135, 1991

    PubMed  Google Scholar 

  19. Liu TJ: Acute biliary septic shock. HPB Surg 2:177–183, 1990

    PubMed  Google Scholar 

  20. Su CH, Lui WY, Peng FK: Relative prevalence of gallstones disease in Taiwan. A nationwide cooperative study. Dig Dis Sci 37:764–768, 1992

    PubMed  Google Scholar 

  21. Sheen-Chen SM, Chou FF: Postoperative choledochoscopy: Is routine antibiotic prophylaxis necessary? A prospective randomized study. Surgery 115:170–175, 1994

    PubMed  Google Scholar 

  22. Jeng KS, Yang FS, Chiang HJ, Obts I: Bile duct stents in the management of hepatolithiasis with long-segment intrahepatic biliary strictures. Br J Surg 79:663–666, 1992

    PubMed  Google Scholar 

  23. Huang CS, Tai FC, Shi MY, et al: Complications of laparoscopic cholecystectomy: An analysis of 200 cases. J Formosan Med Assoc 91:785–792, 1992

    PubMed  Google Scholar 

  24. Mo LR, Hwang MH, Yehu SK, Yong JC, Lin C: Percutaneous transhepatic choledochoscopic electrohydraulic lithotripsy (PTCS-EHL) of common bile duct stones. Gastrointestinal Endosc 34:122–125, 1988

    Google Scholar 

  25. Chen MF, Jan YY: Percutaneous transhepatic cholangioscopic lithotripsy. Br J Surg 77:530–532, 1990

    PubMed  Google Scholar 

  26. Matsumoto Y, Fujii H, Yoshioka M, Sekikawa T, Wada T, Yamamoto M, Eguchi H, Sugahara K: Biliary strictures as a cause of primary intrahepatic bile duct stones. World J Surg 10:867–875, 1986

    PubMed  Google Scholar 

  27. Cetta FM: Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones. Hepatology 6:482–489, 1986

    PubMed  Google Scholar 

  28. Ayres RCS, Neuberger JM, Shaw J, Joplin R, Adams DH: Intracellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of proinflammatory cytokines. Gut 34:1245–1249, 1993

    PubMed  Google Scholar 

  29. Volpes R, Van den Oord JJ, Desmet VJ, Yap S-H: Induction of intracellular adhesion molecule-1 (CD54) on human hepatoma cell line HepG2: Influence of cytokines and hepatitis B virus-DNA transfection. Clin Exp Immunol 87:71–75, 1992

    PubMed  Google Scholar 

  30. Kvale D, Brandtzaeg P: Immune modulation of adhesion molecule ICAM-1 (CD54) and LFA (CD58) in human hepatocytic cell lines. J Hepatol 17:347–352, 1993

    PubMed  Google Scholar 

  31. Thomson WA, Satoh S, Nussler AK, Tamura K, Woo J, Gavaler J, van Thiel DH: Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocyte. Clin Exp Immunol 95:83–90, 1994

    PubMed  Google Scholar 

  32. Sherlock S, Dooley J: Disease of the Liver and Biliary System, 9th ed. Blackwell Scientific, pp 202–203

  33. Heufelder AE, Bahn RS: Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthal-mopathy and thyroid diseases. Clin Exp Immunol 92:296–302, 1993

    PubMed  Google Scholar 

  34. Tabata M, Nakayama F: Bacteria and gallstones. Etiological significance Dig Dis Sci 26:218–224, 1981

    Google Scholar 

  35. Maki T: Pathogenesis of calcium bilirubinate gallstones: role ofE. coli, β-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg 164:90–100, 1966

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sheen-Chen, SM., Eng, HL., Cheng, YF. et al. Circulating intercellular adhesion molecule-1 (ICAM-1) in patients with hepatolithiasis. Digest Dis Sci 41, 1682–1686 (1996). https://doi.org/10.1007/BF02087925

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087925

Key words

  • intercellular adhesion molecule-1
  • hepatolithiasis